Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Financing

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Sep 22, 2022 10:44pm

124 Views

Post# 34980815

RE:RE:RE:RE:Financing

A 5% dilution took us down temporarily almost 30% from 0.35.

StevenBirch wrote: Yes this has been hanging over the stock for weeks and now it's out of the way. The stock will always trade down to where the PP was done, in this case before the announcement rather than after so it should be a gradual climb from here as we get closer to the next update.

Yajne wrote: P.S. nice to 'non-brokered' as well...specifically the Mackie was nowhere near this thing. Non-brokered financings are usually a good omen IMO, the fact that they were able to round up the funds fairly easily incl $600K from insiders which is also a good signal.

Yajne wrote: IMO, we go up from here in anticipation of BTD and AA. The 'writing on the wall' was obvious after Q2 released for anybody with a basic knowledge of financial statements. They had cash to end of Q3 or possibly a month more based on monthly burn rate. This small tuck-in financing is IMO exactly what the doctor ordered at this point and puts the $$ question behind us until will into 2023 when SP should be a completely different level when BTD and AA achieved...and talk of other indications begins to enter the discussion again. So KUDOS to TLT mgmt for this small financing.

enriquesuave wrote: Good. At least company has about $3.6 Million in cash now until at least a year and now will prepare for GBM and NSCLC as well. They can't wait till last minute. Next catalyst will see warrants excercised I hope and more cash.